Start-Up Raises $200 Million to Speed Up Drug Trials

Opinion: Technology can make clinical trials equitable and accessible

Hemant's Year-End Letter to LPs

Focusing on Europe

General Catalyst Backs Clinical Trials Startup Vial

Maven Clinic Raises $90M Series E at a $1.35B Valuation

General Catalyst Named No. 1 Most Prominent Digital Health Investors

Applications Security Startup Apiiro Pulls in $100M Series B from A-list Investors

Startups, Investors Bet on Remote Work Future

Renaissance in Precision Neuroscience Explained

General Catalyst Goes Global—Partners with UK's Largest Hospital System

The 41 Most Important VCs in Boston

General Catalyst Partners with WellSpan Health on Digital Health

Marc Harrison To Join General Catalyst from Intermountain

General Catalyst’s Quentin Clark on Workforce Health and How Employers Can Support Their People

Defying Pullback In Investments, General Catalyst Launches $670 Million Healthcare Fund

How The Collison Brothers Built Stripe Into A $95 Billion Unicorn

Why Stripe is Fast Company's No. 1 Most Innovative Company of 2022

A Race to Rethink Care After a Dire Diagnosis

15 Top Investors Share Their Best 2022 Healthcare Predictions

Group Backed by Top Companies Moves to Combat A.I. Bias in Hiring

Ex-Stripe Execs, VCs Launch New Nonprofit to Promote ‘Responsible’ Innovation

Grammarly raises $200M at a $13B valuation to make you an even better writer using AI

Why General Catalyst, a16z, And Rock Health Are Backing Ribbon Health’s $43.5 Million Funding Round

Why General Catalyst, a16z, And Rock Health Are Backing Ribbon Health’s $43.5 Million Funding Round